Lymph Node Targeting

Lymph Node Targeting is a strategic delivery approach in nanoparticle-based immunotechnology that selectively directs vaccine antigens and adjuvants to lymph nodes, the primary sites of immune activation, thereby enhancing antigen presentation and adaptive immune responses through precise spatial localization.

154

Publications

11.6K

Citations

1.1K

Authors

319

Institutions

Publications per year

2017–2026

75

Authors

1.1K

  1. SW
    Shujun Wang

    Shenyang Pharmaceutical University, China

    6 publications · 101 citations

    5

    h-index

  2. JC
    Jianjun Cheng

    University of Illinois Urbana-Champaign, United States

    5 publications · 416 citations

    5

    h-index

  3. BG
    Bruno G. De Geest

    Ghent University, Belgium

    5 publications · 318 citations

    5

    h-index

  4. LT
    Li Tang

    University of Illinois Urbana-Champaign, United States

    4 publications · 322 citations

    4

    h-index

  5. QY
    Qian Yin

    University of Illinois Urbana-Champaign, United States

    4 publications · 329 citations

    4

    h-index

1–5 of 1.1K

Venues

  1. Biomaterials

    10 publications · 1.2K citations

    10

    h-index

  2. PubMed

    Repository · 5 publications · 267 citations

    5

    h-index

  3. Advanced Science

    5 publications · 226 citations

    5

    h-index

  4. International Journal of Pharmaceutics

    4 publications · 173 citations

    4

    h-index

  5. Carbohydrate Polymers

    4 publications · 101 citations

    4

    h-index

1–5